yes and no.
from a Cash flow perspective we may have already spent the money but that doesn't mean from an accrual perspective they're "free" and in the long run it is the margin that will set the share valuation, not the revenue
- Forums
- ASX - By Stock
- MSB
- Ann: Ryoncil Pricing Set and Available This Quarter
MSB
mesoblast limited
Add to My Watchlist
1.85%
!
$1.65

Ann: Ryoncil Pricing Set and Available This Quarter, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
0.030(1.85%) |
Mkt cap ! $2.108B |
Open | High | Low | Value | Volume |
$1.64 | $1.67 | $1.63 | $4.884M | 2.962M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10583 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 16415 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10583 | 1.650 |
2 | 23000 | 1.645 |
4 | 27999 | 1.640 |
1 | 876 | 1.635 |
4 | 18446 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 10415 | 2 |
1.665 | 30000 | 2 |
1.670 | 16598 | 2 |
1.675 | 4000 | 1 |
1.680 | 17509 | 4 |
Last trade - 16.12pm 27/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online